» Articles » PMID: 20584589

Lymph Node Management in Clinically Node-negative Patients with Papillary Thyroid Carcinoma

Overview
Publisher Elsevier
Date 2010 Jun 30
PMID 20584589
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: Systematic lymph node dissection in patients with papillary thyroid carcinoma (PTC) remains controversial. The objective of this study was to study the pattern of lymph node spread in patients with PTC clinically node-negative and then to propose a lymph node management strategy.

Methods: We retrospectively reviewed the records of patients who had undergone total thyroidectomy and a systematic central neck dissection (CND) and lateral neck dissection. Ninety patients with PTC without lymph nodes metastases (LNM) detected on preoperative palpation and ultrasonographic examination were included.

Results: Forty-one patients (45.5%) had LNM. Twenty-eight patients (31%) had a central and a lateral involvement. Thirteen patients (14.5%) had only a central involvement. All the patients without LNM in the central compartment were also free in the lateral compartment. There was no correlation between LNM status and TNM staging. The largest LNM in the central compartment was smaller than or equal to 5mm in 66% of the cases, and that could explain the lack of sensitivity of the preoperative ultrasonographic examination.

Conclusion: CND could be considered at preoperative or intraoperative diagnosis of PTC whereas lateral neck dissection should be performed only in patients with preoperative suspected and/or intraoperatively proven LNM. Systematic CND allows an objective evaluation of lymph node status in this central cervical area where the LNM are particularly small and difficult to detect preoperatively.

Citing Articles

Factors associated with occult lateral lymph node metastases in patients with clinically lymph node negative papillary thyroid carcinoma: a systematic review and meta-analysis.

Fei Y, Wang B, Yao X, Wu J Front Endocrinol (Lausanne). 2024; 15:1353923.

PMID: 39493782 PMC: 11527613. DOI: 10.3389/fendo.2024.1353923.


A nomogram for risk stratification of central cervical lymph node metastasis in patients with papillary thyroid carcinoma.

Zou Y, Shi Y, Bi H, Tan J, Guo Q, Qin Y Quant Imaging Med Surg. 2024; 14(7):5084-5098.

PMID: 39022275 PMC: 11250316. DOI: 10.21037/qims-24-284.


Prevalence of Occult Central Lymph Node Metastasis by Tumor Size in Papillary Thyroid Carcinoma: A Systematic Review and Meta-Analysis.

Tang L, Qu R, Park J, Simental A, Inman J Curr Oncol. 2023; 30(8):7335-7350.

PMID: 37623013 PMC: 10453273. DOI: 10.3390/curroncol30080532.


The risk of central nodal metastasis based on prognostic factors of the differentiated thyroid carcinoma: a systematic review and meta-analysis study.

Hafez L, Elkomos B, El-Shafaei M, Omran H, Saad A Eur Arch Otorhinolaryngol. 2023; 280(6):2675-2686.

PMID: 36759363 PMC: 10175472. DOI: 10.1007/s00405-023-07863-8.


Prediction of Cervical Lymph Nodes Metastasis in Papillary Thyroid Carcinoma (PTC) Using Nodal Staging Score (NSS).

Zhang J, Jia G, Su Y, Zhang Z, Xiong H, Xu Q J Oncol. 2022; 2022:9351911.

PMID: 36284638 PMC: 9588335. DOI: 10.1155/2022/9351911.